Exacerbating the burden of cardiovascular disease: how can we address cardiopulmonary risk in individuals with chronic obstructive pulmonary disease?

被引：5
|
作者：
Shrikrishna, Dinesh [1 ]
Taylor, Clare J. [2 ]
Stonham, Carol [3 ,4 ]
Gale, Chris P. [5 ,6 ,7 ]
机构：
[1] Musgrove Pk Hosp, Somerset NHS Fdn Trust, Dept Resp Med, Parkfield Dr, Taunton TA1 5DA, Somerset, England
[2] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxfordshire, England
[3] Primary Care Resp Soc PCRS, Knowle, England
[4] NHS Gloucestershire Integrated Care Board, Gloucester Business Pk, Gloucester GL3 4FE, England
[5] Leeds Teaching Hosp NHS Trust, Dept Cardiol, Leeds, England
[6] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, England
[7] Univ Leeds, Leeds Inst Data Analyt, Leeds, England
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷 / 04期
关键词：
MORTALITY;
D O I：
10.1093/eurheartj/ehad669
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：247 / 249
页数：3
相关论文
共 50 条
  • [41] Particulate Matter and Cardiovascular Risk in Adults with Chronic Obstructive Pulmonary Disease
    Alexeeff, Stacey E.
    Deosaransingh, Kamala
    Liao, Noelle S.
    Van den Eeden, Stephen K.
    Schwartz, Joel
    Sidney, Stephen
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (02) : 159 - 167
  • [42] Control of Cardiovascular Risk Factors in Patients with Chronic Obstructive Pulmonary Disease
    Hawkins, Nathaniel M.
    Peterson, Sandra
    Ezzat, Allison M.
    Vijh, Rohit
    Virani, Sean A.
    Gibb, Andrew
    Mancini, G. B. John
    Wong, Sabrina T.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (07) : 1102 - 1111
  • [43] Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease
    Rogliani, Paola
    Calzetta, Luigino
    Matera, Maria Gabriella
    di Daniele, Nicola
    Girolami, Andrea
    Cazzola, Mario
    Ora, Josuel
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (06) : 737 - 750
  • [44] Dual Bronchodilators and β-Blockade for Cardiovascular Risk in Chronic Obstructive Pulmonary Disease
    Zaheen, Ahmad
    Anand, Anju
    Stanbrook, Matthew B.
    JAMA INTERNAL MEDICINE, 2018, 178 (05) : 730 - +
  • [45] The global burden of chronic obstructive pulmonary disease, number 3, The natural history of chronic obstructive pulmonary disease
    Mannino, DM
    Watt, G
    Hole, D
    Gillis, C
    Hart, C
    McConnachie, A
    Smith, GD
    Upton, M
    Hawthorne, V
    Sin, DD
    Man, SFP
    Van Eeden, S
    Mapel, DW
    Vestbo, J
    EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (03) : 627 - 643
  • [46] Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
    Rao, Shishir
    Nazarzadeh, Milad
    Li, Yikuan
    Canoy, Dexter
    Mamouei, Mohammad
    Salimi-Khorshidi, Gholamreza
    Rahimi, Kazem
    HEART, 2023, 109 (16) : 1216 - 1222
  • [47] Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review
    Sa-Sousa, Ana
    Rodrigues, Cidalia
    Jacome, Cristina
    Cardoso, Joao
    Fortuna, Ines
    Guimaraes, Miguel
    Pinto, Paula
    Sarmento, Pedro Morais
    Baptista, Rui
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [48] Chronic obstructive pulmonary disease and cardiovascular events
    Villar Alvarez, Felipe
    de Miguel Diez, Javier
    Alvarez-Sala, Jose Luis
    ARCHIVOS DE BRONCONEUMOLOGIA, 2008, 44 (03): : 152 - 159
  • [49] Chronic obstructive pulmonary disease and cardiovascular system
    Gurgun, Alev
    Gurgun, Cemil
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2008, 56 (04): : 464 - 471
  • [50] CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR COMORBIDITY
    Aisanov, Z. R.
    Chuchalin, A. G.
    Kalmanova, E. N.
    KARDIOLOGIYA, 2019, 59 (08) : 24 - 36
12345